Cold Sore Fever Blister Treatment by TARGET Corporation Docosanol Cream, 10%

Cold Sore Fever Blister Treatment by

Drug Labeling and Warnings

Cold Sore Fever Blister Treatment by is a Otc medication manufactured, distributed, or labeled by TARGET Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

COLD SORE FEVER BLISTER TREATMENT- docosanol cream 
TARGET Corporation

----------

Docosanol Cream, 10%

Active ingredient

 Docosanol  10%

Purpose

Cold sore/fever blister treatment

Uses

• treats cold sores/fever blisters on the face or lips
• shortens healing time and duration of symptoms:
  • tingling, pain, burning, and/or itching

Warnings

Allergy Alert: This product may cause a severe allergic reaction. Symptoms may include:

• hives
• facial swelling
• wheezing/difficulty
• shock
• rash

If an allergic reaction occurs, stop use and seek medical help right away.

For external use only

Do not use

•  if you are allergic to any ingredient in this product

When using this product

• apply only to the affected areas
• do not use in or near the eyes
• avoid applying directly inside your mouth
• do not share this product with anyone. This may spread the infection.

Stop use and ask a doctor if

• your cold sore gets worse or the cold sore is not healed within 10 days

Keep out of reach of children.

 If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• adults and children 12 years or over:
  • wash hands before and after applying cream
  • apply to affected area on the face or lips at the first sign of cold sore/fever blister (tingle).
  • early treatment ensures the best results
  • rub in gently but completely
  • use 5 times a day until healed
• children under 12 years: ask a doctor

Other information

• store at 20° to 25°C (68° to 77°F)
• do not freeze

Inactive ingredients

benzyl alcohol, light mineral oil, propylene glycol, purified water, sucrose distearate, sucrose stearate

Questions or comments?

Call 

Principal Display Panel

†Compare to the active ingredient in Abreva®

Docosanol Cream, 10%

Cold sore/fever blister treatment

• Only FDA approved medicine to shorten healing time*
• Cold sore treatment

NET WT g (oz)

*Docosanol Cream, 10% contains the only OTC medicine approved by the FDA to shorten healing time and duration of symptoms.

†This product is not manufactured or distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, distributor of Abreva®.

RETAIN THIS INSERT FOR FULL PRODUCT USES, DIRECTIONS AND WARNINGS

Distributed by Target Corporation

Package Label

TARGET Cold Sore Fever Blister Treatment

COLD SORE FEVER BLISTER TREATMENT 
docosanol cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 82442-112
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DOCOSANOL (UNII: 9G1OE216XY) (DOCOSANOL - UNII:9G1OE216XY)	DOCOSANOL	100 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
BENZYL ALCOHOL (UNII: LKG8494WBH)
LIGHT MINERAL OIL (UNII: N6K5787QVP)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
WATER (UNII: 059QF0KO0R)
SUCROSE DISTEARATE (HLB 5) (UNII: 33X4X4B90S)
SUCROSE STEARATE (UNII: 274KW0O50M)

Product Characteristics
Color	white	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 82442-112-07	1 in 1 PACKAGE	07/31/2024	12/31/2025
1		2 g in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
ANDA	ANDA212385	07/31/2024	12/31/2025

Labeler - TARGET Corporation (006961700)

Revised: 12/2025

Document Id: fbcdc5ea-d995-4819-b7f5-a7dee17f5bd5

34390-5

Set id: 6e4022a0-6dc1-4c79-8aa2-2cf9a985261f

Version: 3

Effective Time: 20251223